Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
Clinical trial NCT06045195 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06045195
- Sponsor
- University of Cologne
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.